CAS: 1628805-46-8
IDH-305
CAS:1628805-46-8
IDH-305: Oral, mutation-specific IDH1 inhibitor, 200x selective for R132 mutants; IC50: 27/28/6.14 nM for R132H/C/WT.
Formula:
C23H22F4N6O2
Purity:
99.13%
Color and Shape:
Solid
Molecular weight:
490.45
Ref: TM-T15550
| 1mg | 56.00 € | ||
| 5mg | 124.00 € | ||
| 10mg | 172.00 € | ||
| 25mg | 344.00 € | ||
| 50mg | 520.00 € | ||
| 1mL*10mM (DMSO) | 136.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
![(4R)-4-[(1S)-1-Fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethy…](https://static.cymitquimica.com/products/IN/thumb/DA00IKMH.jpg)
(4R)-4-[(1S)-1-Fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethyl]amino]-4-pyrimidinyl]-2-oxazolidinone
CAS:1628805-46-8
Formula:
C23H22F4N6O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
490.4534
Ref: IN-DA00IKMH
| 1mg | 142.00 € | ||
| 5mg | 255.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
IDH 305
CAS:1628805-46-8
IDH 305 is a retinoic acid that is used in the treatment of intrahepatic cholangiocarcinoma …
Formula:
C23H22F4N6O2
Purity:
Min. 95%
Molecular weight:
490.45 g/mol
Ref: 3D-DQC80546
| 1mg | 338.00 € | ||
| 5mg | 636.00 € | ||
| 10mg | 969.00 € | ||
| 25mg | 1,710.00 € | ||
| 50mg | 2,736.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
